Events
Feb. 15, 2008
The “1st Berlin Conference on IP in Life Sciences – Smart Clinical Trials” is designed to give deeper insights into the design of clinical trials with respect to prolonging IP life span through pediatric use data, the set-up of first-in-man studies of biologicals, legal risks and liabilities.
Biotech executives from late-stage companies will share the lessons they learned from the outcome of recent clinical trials. Furthermore, senior experts from big pharma companies will also be on hand to address questions involving successful licensing.
Biotech and pharmaceutical company executives and advisors responsible for clinical trials, licensing and IP strategy and protection can‘t afford to miss this high-level event. This is also true for advisors and executives practicing in pharmaceuticals, IP, licensing and venture capital.
Visit also: http://www.biocom.de
